This infographic reviews the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) approved for treatment of type 2 diabetes, including their glycemic and extraglycemic effects. Clinical practice recommendations for the use of GLP-1 RAs are provided, along with top tips for initiating therapy effectively and safely in the clinic.
- Provider:Pri-Med Institute
- Activity Link: https://www.pri-med.com/online-cme-ce/interactive-learning/navigating-glp-ra-therapy-type-2-diabetes
- Start Date: 2024-11-01 05:00:00
- End Date: 2024-11-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 0.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Internal Medicine
Subscribe
Login
0 Comments
Oldest